Cargando…
Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid
Propionic acid (PPA) is a ubiquitous short-chain fatty acid which is a fermentation product of the enteric microbiome and present or added to many foods. While PPA has beneficial effects, it is also associated with human disorders, including autism spectrum disorders (ASDs). We previously demonstrat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744079/ https://www.ncbi.nlm.nih.gov/pubmed/29312285 http://dx.doi.org/10.3389/fimmu.2017.01670 |
_version_ | 1783288681407184896 |
---|---|
author | Frye, Richard E. Nankova, Bistra Bhattacharyya, Sudeepa Rose, Shannon Bennuri, Sirish C. MacFabe, Derrick F. |
author_facet | Frye, Richard E. Nankova, Bistra Bhattacharyya, Sudeepa Rose, Shannon Bennuri, Sirish C. MacFabe, Derrick F. |
author_sort | Frye, Richard E. |
collection | PubMed |
description | Propionic acid (PPA) is a ubiquitous short-chain fatty acid which is a fermentation product of the enteric microbiome and present or added to many foods. While PPA has beneficial effects, it is also associated with human disorders, including autism spectrum disorders (ASDs). We previously demonstrated that PPA modulates mitochondrial dysfunction differentially in subsets of lymphoblastoid cell lines (LCLs) derived from patients with ASD. Specifically, PPA significantly increases mitochondrial function in LCLs that have mitochondrial dysfunction at baseline [individuals with autistic disorder with atypical mitochondrial function (AD-A) LCLs] as compared to ASD LCLs with normal mitochondrial function [individuals with autistic disorder with normal mitochondrial function (AD-N) LCLs] and control (CNT) LCLs. PPA at 1 mM was found to have a minimal effect on expression of immune genes in CNT and AD-N LCLs. However, as hypothesized, Panther analysis demonstrated that 1 mM PPA exposure at 24 or 48 h resulted in significant activation of the immune system genes in AD-A LCLs. When the effect of PPA on ASD LCLs were compared to the CNT LCLs, both ASD groups demonstrated immune pathway activation, although the AD-A LCLs demonstrate a wider activation of immune genes. Ingenuity Pathway Analysis identified several immune-related pathways as key Canonical Pathways that were differentially regulated, specifically human leukocyte antigen expression and immunoglobulin production genes were upregulated. These data demonstrate that the enteric microbiome metabolite PPA can evoke atypical immune activation in LCLs with an underlying abnormal metabolic state. As PPA, as well as enteric bacteria which produce PPA, have been implicated in a wide variety of diseases which have components of immune dysfunction, including ASD, diabetes, obesity, and inflammatory diseases, insight into this metabolic modulator may have wide applications for both health and disease. |
format | Online Article Text |
id | pubmed-5744079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57440792018-01-08 Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid Frye, Richard E. Nankova, Bistra Bhattacharyya, Sudeepa Rose, Shannon Bennuri, Sirish C. MacFabe, Derrick F. Front Immunol Immunology Propionic acid (PPA) is a ubiquitous short-chain fatty acid which is a fermentation product of the enteric microbiome and present or added to many foods. While PPA has beneficial effects, it is also associated with human disorders, including autism spectrum disorders (ASDs). We previously demonstrated that PPA modulates mitochondrial dysfunction differentially in subsets of lymphoblastoid cell lines (LCLs) derived from patients with ASD. Specifically, PPA significantly increases mitochondrial function in LCLs that have mitochondrial dysfunction at baseline [individuals with autistic disorder with atypical mitochondrial function (AD-A) LCLs] as compared to ASD LCLs with normal mitochondrial function [individuals with autistic disorder with normal mitochondrial function (AD-N) LCLs] and control (CNT) LCLs. PPA at 1 mM was found to have a minimal effect on expression of immune genes in CNT and AD-N LCLs. However, as hypothesized, Panther analysis demonstrated that 1 mM PPA exposure at 24 or 48 h resulted in significant activation of the immune system genes in AD-A LCLs. When the effect of PPA on ASD LCLs were compared to the CNT LCLs, both ASD groups demonstrated immune pathway activation, although the AD-A LCLs demonstrate a wider activation of immune genes. Ingenuity Pathway Analysis identified several immune-related pathways as key Canonical Pathways that were differentially regulated, specifically human leukocyte antigen expression and immunoglobulin production genes were upregulated. These data demonstrate that the enteric microbiome metabolite PPA can evoke atypical immune activation in LCLs with an underlying abnormal metabolic state. As PPA, as well as enteric bacteria which produce PPA, have been implicated in a wide variety of diseases which have components of immune dysfunction, including ASD, diabetes, obesity, and inflammatory diseases, insight into this metabolic modulator may have wide applications for both health and disease. Frontiers Media S.A. 2017-12-22 /pmc/articles/PMC5744079/ /pubmed/29312285 http://dx.doi.org/10.3389/fimmu.2017.01670 Text en Copyright © 2017 Frye, Nankova, Bhattacharyya, Rose, Bennuri and MacFabe. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Frye, Richard E. Nankova, Bistra Bhattacharyya, Sudeepa Rose, Shannon Bennuri, Sirish C. MacFabe, Derrick F. Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid |
title | Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid |
title_full | Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid |
title_fullStr | Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid |
title_full_unstemmed | Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid |
title_short | Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid |
title_sort | modulation of immunological pathways in autistic and neurotypical lymphoblastoid cell lines by the enteric microbiome metabolite propionic acid |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744079/ https://www.ncbi.nlm.nih.gov/pubmed/29312285 http://dx.doi.org/10.3389/fimmu.2017.01670 |
work_keys_str_mv | AT fryericharde modulationofimmunologicalpathwaysinautisticandneurotypicallymphoblastoidcelllinesbytheentericmicrobiomemetabolitepropionicacid AT nankovabistra modulationofimmunologicalpathwaysinautisticandneurotypicallymphoblastoidcelllinesbytheentericmicrobiomemetabolitepropionicacid AT bhattacharyyasudeepa modulationofimmunologicalpathwaysinautisticandneurotypicallymphoblastoidcelllinesbytheentericmicrobiomemetabolitepropionicacid AT roseshannon modulationofimmunologicalpathwaysinautisticandneurotypicallymphoblastoidcelllinesbytheentericmicrobiomemetabolitepropionicacid AT bennurisirishc modulationofimmunologicalpathwaysinautisticandneurotypicallymphoblastoidcelllinesbytheentericmicrobiomemetabolitepropionicacid AT macfabederrickf modulationofimmunologicalpathwaysinautisticandneurotypicallymphoblastoidcelllinesbytheentericmicrobiomemetabolitepropionicacid |